847 filings
8-K
ADXS
Ayala Pharmaceuticals, Inc.
20 Dec 19
Advaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update
4:31pm
10-K
2019 FY
ADXS
Ayala Pharmaceuticals, Inc.
Annual report
20 Dec 19
4:03pm
4
Gutierrez Andres
25 Oct 19
Advaxis / Andres Gutierrez ownership change
4:31pm
4
Berman Richard J
25 Oct 19
Advaxis / RICHARD J BERMAN ownership change
4:31pm
4
Sidransky David
25 Oct 19
Advaxis / DAVID SIDRANSKY ownership change
4:30pm
4
raye2j5 uq47c
25 Oct 19
Advaxis / Molly Henderson ownership change
4:30pm
4
ewssa2bh8b
25 Oct 19
Advaxis / RONI APPEL ownership change
4:30pm
4
54niohu7ev46 mhh7hgp
25 Oct 19
Advaxis / Samir N Khleif ownership change
4:30pm
4
i6m49osm
25 Oct 19
Advaxis / JAMES P PATTON ownership change
4:30pm
4
r2qt0
25 Oct 19
Advaxis / Kenneth A Berlin ownership change
4:30pm
8-K
fski6 xceu7pq7rh
25 Oct 19
Advaxis Announces Business and Pipeline Update
12:00am
8-K
fx0zazs1ixetkq
4 Oct 19
Other Events
4:31pm
8-K
5dju0sgydfl
13 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
5c4bi
9 Sep 19
Advaxis Reports Fiscal Third Quarter 2019 Financial Results and Provides Pipeline Update
4:30pm
8-K
ojs8f9 hgtxv53o8iw
6 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
35gv 8gor
22 Aug 19
Advaxis, Inc. Issues Letter to Shareholders
4:15pm
8-K
ln4bv
31 Jul 19
Material Modifications to Rights of Security Holders
4:15pm
SC 13G
8n9eftu9g7i3
31 Jul 19
Advaxis, Inc.
1:33pm
8-K
tntdsgtfm
25 Jul 19
Advaxis, Inc. Announces Pricing of $16 Million Public Offering
5:19pm